Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis

Rebecca Russ1, Frank J Slack

  • 1Department of Molecular, Cellular and Developmental Biology, Yale University, P.O. Box 208103, New Haven, CT 06520, USA.

Pulmonary Medicine
|December 23, 2011
PubMed

Insights

MicroRNA (miRNA) dysregulation, especially downregulation, is linked to lung cancer development and is influenced by cigarette smoke exposure. Understanding these changes can improve lung cancer diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in gene regulation, and their dysregulation is implicated in lung cancer.
  • Downregulation of tumor-suppressive miRNAs can activate oncogenes, while upregulation of oncomiRs can inhibit tumor suppressors.
  • Cigarette smoke is a known carcinogen that can induce miRNA dysregulation through genetic or epigenetic alterations.

Purpose of the Study:

  • To investigate the role of microRNA dysregulation in lung cancer development.
  • To explore the impact of cigarette smoke exposure on miRNA expression patterns.
  • To understand the relationship between miRNA changes, smoking habits, and age.

Main Methods:

  • The study reviews existing research on miRNA dysregulation in lung cancer.
  • It examines the mechanisms by which cigarette smoke affects miRNA expression, including genetic and epigenetic damage.
  • Correlation analysis is used to link miRNA dysregulation with age, smoking intensity, duration, and cessation.

Main Results:

  • miRNA downregulation is a common feature in lung cancer development.
  • Cigarette smoke exposure significantly contributes to miRNA dysregulation.
  • Age, intensity, and duration of smoking, as well as cessation duration, correlate with altered miRNA expression.

Conclusions:

  • Dysregulated miRNAs are key players in lung carcinogenesis, particularly in response to cigarette smoke.
  • Understanding miRNA alterations offers potential for novel lung cancer biomarkers and therapeutic strategies.
  • Further research into miRNA regulation by smoking is crucial for advancing lung cancer prevention and treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.